Published in Scand J Haematol Suppl on January 01, 1971
In vivo behavior of fibrinogen fragment D in experimental renal, hepatic and reticuloendothelial dysfunction. Am J Pathol (1973) 0.86
Detection of fibrinogen antigens with two latex techniques applied to urine concentrates. J Clin Pathol (1973) 0.84
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods (1995) 16.00
Flow cytometry of apoptotic cell death. J Immunol Methods (2000) 2.30
Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. J Clin Oncol (1989) 2.12
Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab (1995) 2.03
Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet (1999) 1.63
The feasibility of total ankle prosthesis for severe arthropathy in haemophilia and prothrombin deficiency. Haemophilia (2006) 1.55
Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells. Exp Hematol (1991) 1.41
Clinical course in 28 unselected patients with aplastic anaemia treated with anabolic steroids. Br J Haematol (1979) 1.39
Clinical pharmacokinetics of doxorubicin. Clin Pharmacokinet (1988) 1.37
Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab (2001) 1.18
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol Res (2010) 1.18
In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetologia (1993) 1.09
A method for quantification of peripheral blood admixture in bone marrow aspirates. Exp Hematol (1980) 1.09
Apoptosis and programmed cell death in health and disease. Adv Clin Chem (1994) 1.04
Clinical course and survival in 16 patients with localized plasmacytoma. Scand J Haematol (1984) 1.02
Apoptotic cell death kinetics in vitro depend on the cell types and the inducers used. Apoptosis (2004) 1.01
A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob Agents Chemother (1985) 1.01
Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood (1982) 0.98
Hageman factor, a novel sialoglycoprotein with esterase activity. Biochim Biophys Acta (1965) 0.96
The effect of lithium on platelet aggregation and platelet release reaction. Thromb Res (1977) 0.96
Early features of apoptosis detected by four different flow cytometry assays. Apoptosis (1998) 0.94
Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients. Cancer Chemother Pharmacol (1987) 0.94
A simple test for measuring platelet aggregation. Results in von Willebrand's disease and uraemia. Thromb Diath Haemorrh (1969) 0.94
Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry. Blood (1992) 0.92
Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cells. Exp Cell Res (1988) 0.91
Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia. Clin Pharmacol Ther (1977) 0.91
The immunoglobulins in Hodgkin's disease. Eur J Cancer (1976) 0.91
Apoptosis: molecular mechanisms and implications for cancer chemotherapy. Pharm World Sci (1997) 0.91
Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion. Cancer Chemother Pharmacol (1987) 0.90
Treatment of acute lymphoblastic leukemia in adolescents and a-dults: A retrospective study of 41 patients (1970-1973). Blood (1975) 0.90
Clinical course and survival after elective splenectomy in 19 patients with primary myelofibrosis. Br J Haematol (1977) 0.89
Familial thrombopathic thrombocytopenia. Br J Haematol (1968) 0.88
Monocyte purification with counterflow centrifugation monitored by continuous flow cytometry. J Immunol Methods (1981) 0.88
Simultaneous measurement of DNA content and cell-surface immunofluorescence of human bone marrow cells using a single laser flow cytometer. Cytometry (1990) 0.88
Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematol (1997) 0.87
Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. Bone Marrow Transplant (1994) 0.87
Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent. Thromb Diath Haemorrh (1967) 0.87
Platelet function and von Willebrand's disease. Lancet (1968) 0.86
Normal diurnal rhythm in the excretion of water and electrolytes after renal transplantation. Clin Nephrol (1974) 0.86
Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol (1998) 0.85
Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. BJOG (2000) 0.85
Cytosine arabinoside binding to human plasma proteins. Arch Int Pharmacodyn Ther (1977) 0.85
Simplified method for DNA and protein staining of human hematopoietic cell samples. Cytometry (1981) 0.85
Blastomycosis treated successfully with miconazole. Trop Geogr Med (1979) 0.85
Chronic lymphocytic leukaemia presenting as renal failure with lymphocytic infiltration of the kidneys. Neth J Med (1992) 0.84
Observations on platelet ultrastructure in familial thrombocytopathic thrombocytopenia. Am J Pathol (1968) 0.84
Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA. Thromb Haemost (1988) 0.83
Quantitation of anthracyclines in human hematopoietic cell subpopulations by flow cytometry correlated with high pressure liquid chromatography. Cytometry (1985) 0.83
Rapid quantitative determination of four anthracyclines and their main metabolites in human nucleated haematopoietic cells. J Chromatogr (1986) 0.83
[Meningeal carcinomatosis as the first manifestation of gastric adenocarcinoma]. Cas Lek Cesk (2001) 0.83
Different susceptibilities of normal T cells and T cell lines to immunotoxins. Scand J Immunol (1988) 0.82
Preparation and clinical use of factor IX concentrate PPSB according to Soulier. Vox Sang (1969) 0.81
Bone-marrow-profileration patterns in acute myeloblastic leukaemia determined by pulse cytophotometry. Lancet (1975) 0.81
Endogenous mediators in sepsis and septic shock. Adv Clin Chem (1998) 0.81
Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma. Blood (1989) 0.81
Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation. Transplantation (1984) 0.80
Combined immunodeficiency preceding chronic lymphocytic leukemia. Blut (1984) 0.80
Hormonal dependent thrombotic thrombocytopenic purpura (TTP). Scand J Haematol (1983) 0.80
Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma. Cancer Chemother Pharmacol (1986) 0.80
"Incubation period" in Hodgkin's disease. Lancet (1975) 0.80
Sequential occurrence of mitochondrial and plasma membrane alterations, fluctuations in cellular Ca2+ and pH during initial and later phases of cell death. Apoptosis (1999) 0.80
A hereditary abnormal c-fms proto-oncogene in a patient with acute lymphocytic leukaemia and congenital hypothyroidism. Br J Haematol (1985) 0.79
Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's disease. Eur J Cancer Clin Oncol (1983) 0.79
Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion. Clin Pharmacol Ther (1987) 0.79
In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells. Eur J Cancer Clin Oncol (1988) 0.79
A new multichamber counterflow centrifugation rotor with high-separation capacity and versatile potentials. Exp Hematol (1988) 0.79
Treatment of Pseudomonas aeruginosa septicemia in neutropenic patients with ceftazidime. Eur J Clin Microbiol (1985) 0.78
Peripheral blood cell harvests yield primitive multilineage progenitor cells in the CD34+/33- fraction. Int J Artif Organs (1993) 0.78
Intravascular clotting and acute renal failure. Scand J Haematol Suppl (1971) 0.78
Influence of lithium on aggregation, release-reaction and function of human platelets. Pathol Biol (Paris) (1972) 0.78
In vitro effects of estradiol, dydrogesterone, tamoxifen and cyclophosphamide on proliferation vs. death in human breast cancer cells. Cancer Lett (2003) 0.78
Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's disease. Eur J Clin Invest (1977) 0.78
Management of haemophilia in three premature infants. Haemophilia (2007) 0.78
Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes. Proc Natl Acad Sci U S A (1992) 0.78
Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia. Semin Oncol (1985) 0.78
Studies on the cytotoxicity of cytosine arabinoside. Semin Oncol (1985) 0.78
Drug-induced skin reactions in patients with acute non-lymphocytic leukaemia. Eur J Haematol (1987) 0.78
Itraconazole and cyclosporin nephrotoxicity. Lancet (1987) 0.78
Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation. Blood (1986) 0.78
Flow cytometric determination of the S-phase compartment in adult acute leukemia. Acta Haematol (1983) 0.78
Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity. Scand J Immunol (1988) 0.78
Ex vivo evidence of lymphocyte apoptosis in hairy cell leukemia, induced by 2-chlorodeoxyadenosine treatment. Ann Hematol (1998) 0.77
Increased antibody-dependent cytotoxicity mediated by purified monocytes in Hodgkin's disease. Clin Immunol Immunopathol (1983) 0.77
The relation of exposure time and drug concentration in their effect on cloning efficiency after incubation of human bone marrow with cytosine arabinoside. Br J Haematol (1986) 0.77
E-rosette positive acute lymphoblastic leukaemia in adolescents and adults. Br J Haematol (1983) 0.77
DNA strand breaks in human leukocytes induced by chemotherapy and total body irradiation. Leuk Res (1990) 0.77
Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer (1990) 0.77
The effect of cytosine arabinoside upon mitochondrial staining kinetics in human hematopoietic cells. Histochemistry (1986) 0.77
Separation of human bone marrow by counterflow centrifugation monitored by DNA-flowcytometry. Br J Haematol (1984) 0.77
Anthracyclines added to the conditioning regimen for allogeneic bone marrow transplantation are associated with a slower haematopoietic recovery. Bone Marrow Transplant (1989) 0.77
Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state. Leukemia (1994) 0.77
Lithium stimulates thromboxane B2 formation in human platelets. Prostaglandins Med (1981) 0.77
In-vitro studies on phosphorylation and dephosphorylation of cytosine arabinoside in human leukemic cells. Leuk Res (1987) 0.77
Mathematical correlation between ADP-induced platelet aggregation and subsequent disaggregation. A parameter for the velocity of disaggregation. Scand J Haematol (1969) 0.77
Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group. Blood (1989) 0.77
A comparative study concerning the stability of the anticoagulant effect of acenocoumarol and phenprocoumon. Acta Med Scand (1969) 0.76
Cell cycle related uptake, retention and toxicity of idarubicin, daunorubicin and doxorubicin. Anticancer Res (1993) 0.76
Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics. Ann Hematol (1993) 0.76